Drawing for GENEREX BIOTECHNOLOGY

USPTO serial 77492582

GENEREX BIOTECHNOLOGY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MURRAY, DAVID T
Law office
TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with GENEREX BIOTECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John L. DuPre'

JOHN L. DUPRE' HAMILTON, BROOK, SMITH & REYNOLDS, P.C.PO BOX 9133CONCORD, MA 01742-9133UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Nutritional supplements, namely, a glucose composition for administration and absorption of glucose across oral membranes for raising blood glucose level, weight management, and/or increasing energy; pharmaceutical preparations for the treatment of diabetes, obesity, polycystic ovary disease, pain management and deep venous thrombosis (DVT); vaccines for breast cancer, prostate cancer, H5 influenza, ovarian cancer, melanoma cancer, HIV, and SARS; vaccine diagnostic kit comprised of reagents and assays for use in the early detection and screening of type 1 diabetes; Medical diagnostic test strips, namely, blood glucose test strips for use with blood glucose monitor and meterACTIVE—
010Blood glucose monitor and meterACTIVE—
042Research and development in the field pharmaceutical products, nutritional supplements and beverage productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 31, 2012MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 31, 2012ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 4, 2012GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 4, 2012GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 4, 2012CNSISUSPENSION INQUIRY WRITTEN—
Oct 4, 2011GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 4, 2011GNSLLETTER OF SUSPENSION E-MAILED—
Oct 4, 2011CNSLSUSPENSION LETTER WRITTEN—
Oct 4, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 4, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2011ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 27, 2011GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 27, 2011GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 27, 2011CNSISUSPENSION INQUIRY WRITTEN—
Oct 27, 2010GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 27, 2010GNSLLETTER OF SUSPENSION E-MAILED—
Oct 27, 2010CNSLSUSPENSION LETTER WRITTEN—
Oct 27, 2010ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 27, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 18, 2010MAILPAPER RECEIVED—
Apr 21, 2010GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 21, 2010GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 21, 2010CNSISUSPENSION INQUIRY WRITTEN—
Apr 21, 2010RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 21, 2010ALIEASSIGNED TO LIE—
Oct 21, 2009GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 21, 2009GNSLLETTER OF SUSPENSION E-MAILED—
Oct 21, 2009CNSLSUSPENSION LETTER WRITTEN—
Oct 6, 2009RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 6, 2009GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 6, 2009GNSLLETTER OF SUSPENSION E-MAILED—
Apr 6, 2009CNSLSUSPENSION LETTER WRITTEN—
Apr 6, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Apr 6, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 6, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 6, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 17, 2009ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 17, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2009ALIEASSIGNED TO LIE—
Mar 16, 2009MAILPAPER RECEIVED—
Sep 18, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2008DOCKASSIGNED TO EXAMINER—
Jun 12, 2008MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Jun 11, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance